Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Hematology & Oncology Physician in Tucson, AZ
NPI: 1174538995Primary Employer
Banner-University Medical Group
bannerhealth.com
HQ Phone
Get M.D. Ravitharan's Phone Numberphone_androidMobile
Get M.D. Ravitharan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardRI State Medical License
AZ State Medical License
2008 - 2027
RI State Medical License
2006 - 2010
Yale-New Haven Medical Center
Fellowship • Hematology and Medical Oncology
2003 - 2006
Norwalk Hospital/Yale University
Residency • Internal Medicine
2000 - 2003
St. George's University School of Medicine
Medical School
Until 2000
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 145 | 252 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 57 | 145 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 40 | 47 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 39 | 100 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 38 | 38 |
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
Authors: Faiz Anwer, Daniel Persky, Emad Elquza
Journal: Am J Health Syst Pharm
Lead Sponsor: University of Arizona
Intervention / Treatment: DRUG: Bendamustine, DRUG: Cyclophosphamide
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: Canadian Cancer Trials Group
Intervention / Treatment: PROCEDURE: Bone Marrow Biopsy, PROCEDURE: Biospecimen Collection, DRUG: Dexamethasone, DRUG: Cyclophosphamide, DRUG: Cytarabine, DRUG: Prednisone, DRUG: Etoposide, DRUG: Vincristine Sulfate, BIOLOGICAL: Rituximab, DRUG: Methotrexate, PROCEDURE: X-Ray Imaging, DRUG: Vincristine, PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation, PROCEDURE: Bone Marrow Aspiration, BIOLOGICAL: Blinatumomab, DRUG: Mercaptopurine, DRUG: Daunorubicin, PROCEDURE: Lumbar Puncture, DRUG: Pegaspargase, DRUG: Leucovorin Calcium, DRUG: Daunorubicin Hydrochloride
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Vorinostat, OTHER: Laboratory Biomarker Analysis, DRUG: Cytarabine, PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation, DRUG: Idarubicin, DRUG: Daunorubicin Hydrochloride